MarketPeel
Insider Trading Intelligence
Pricing
…
JR

Javier Rodriguez

BTAI
SEE REMARKS · BIOXCEL THERAPEUTICS, INC. · CIK 0001847919
FILING MIX · LIFETIME54%/46%
BUYS
38
SELLS
32
TOTAL VALUE
$81.7K
COMPANIES
1
ACTIVE SINCE
Feb 2021
HOLDINGS NOW
212
AVG SELL PX
$4.57
TRADE KIND
SHOWING 70 / 70
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Javier Rodriguez, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+83.33%-6.09%+1.00%-7.09%-8.95%—
14d6+83.33%-9.42%+1.23%-10.65%-9.10%—
30d6+83.33%-4.49%+3.06%-7.54%-8.32%—
60d6+83.33%-23.80%+5.15%-28.95%-34.08%—
90d6+83.33%-43.59%+7.37%-50.97%-49.86%—
180d6+100.00%-78.11%+7.71%-85.81%-84.31%—
1y6+100.00%-84.68%+18.36%-103.04%-99.42%—
2y6(2 pending)+100.00%-97.70%+40.36%-138.06%-138.77%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BTAI · 212 shares · as of Jun 15, 2026
017,57135,14152,71270,28220222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 38 buys / 32 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
35——212Jun 15, 2026Jun 17, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
35——26,838Jun 15, 2026Jun 17, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,560$1.08$7.1K26,803May 20, 2026May 22, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
17,500——33,363May 4, 2026May 22, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
17,500——52,500May 4, 2026May 22, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
9,000——0May 1, 2026May 7, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
9,000——15,863May 1, 2026May 7, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
35——247Mar 15, 2026Mar 16, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
35——6,863Mar 15, 2026Mar 16, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
33——97Mar 14, 2026Mar 16, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
33——6,828Mar 14, 2026Mar 16, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
70,000——70,282Jan 1, 2026Jan 5, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
35——6,795Dec 15, 2025Dec 15, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
35——282Dec 15, 2025Dec 15, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
33——130Dec 14, 2025Dec 15, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
33——6,760Dec 14, 2025Dec 15, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
35——317Sep 15, 2025Sep 16, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
35——6,727Sep 15, 2025Sep 16, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
33——6,692Sep 14, 2025Sep 16, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
33——163Sep 14, 2025Sep 16, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,000——9,000Aug 1, 2025Aug 5, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,375——6,034Jul 22, 2025Jul 22, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
625——0Jul 22, 2025Jul 22, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
625——6,659Jul 22, 2025Jul 22, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
35——352Jun 15, 2025Jun 16, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
35——1,659Jun 15, 2025Jun 16, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
33——196Jun 14, 2025Jun 16, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
33——1,624Jun 14, 2025Jun 16, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
34——1,591Mar 15, 2025Mar 17, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
34——387Mar 15, 2025Mar 17, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
31——229Mar 14, 2025Mar 17, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
31——1,557Mar 14, 2025Mar 17, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,863$0.55$3.8K23,770Oct 3, 2024Oct 3, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
21,250——30,633Sep 17, 2024Oct 3, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
345$0.69$2389,133Sep 16, 2024Sep 17, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
563——9,478Sep 15, 2024Sep 17, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
563——5,625Sep 15, 2024Sep 17, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
521——3,127Sep 14, 2024Sep 17, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
521——8,915Sep 14, 2024Sep 17, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,875——1,875Jul 22, 2024Apr 1, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
625——625Jul 22, 2024Apr 1, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
361$1.26$4568,394Jun 17, 2024Jun 18, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
562——6,188Jun 15, 2024Jun 18, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
562——8,755Jun 15, 2024Jun 18, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
521——8,193Jun 14, 2024Jun 18, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
521——3,648Jun 14, 2024Jun 18, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,012$2.64$2.7K7,672Apr 4, 2024Apr 8, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
2,250——6,750Mar 15, 2024Apr 8, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
2,250——8,684Mar 15, 2024Apr 8, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
521——4,169Mar 14, 2024Apr 8, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
521——6,434Mar 14, 2024Apr 8, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
521——5,913Dec 14, 2023Dec 18, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
521——4,690Dec 14, 2023Dec 18, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
521——5,392Sep 14, 2023Sep 18, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
521——5,211Sep 14, 2023Sep 18, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
521——5,732Jun 14, 2023Jun 16, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
521——4,871Jun 14, 2023Jun 16, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,785$27.32$48.8K4,350May 15, 2023May 16, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
5,000——6,135May 14, 2023May 16, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
5,000——0May 14, 2023May 16, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
950$19.63$18.6K1,135Mar 15, 2023Mar 16, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
32,000——32,000Mar 15, 2023Mar 16, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,000——9,000Mar 15, 2023Mar 16, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
See Remarks
2,084——2,084Mar 14, 2023Mar 16, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
See Remarks
2,084——6,253Mar 14, 2023Mar 16, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,000——5,000May 14, 2022May 17, 2022 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,337——8,337Mar 14, 2022Mar 16, 2022 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
33,350——33,350Mar 14, 2022Mar 16, 2022 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,000——10,000Aug 16, 2021Aug 18, 2021 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
32,000——32,000Feb 22, 2021Feb 24, 2021 ↗View →
Other insiders · BTAI
Loading peer insiders…
About this filer
CIK 0001847919
ROLE
See Remarks
PRIMARY
BTAI
COMPANIES
1
ACTIVE SINCE
Feb 2021
MARKETPEEL · /INSIDER/0001847919DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback